Skip to main content
logo
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
27.71
-0.03 (-0.11%)
At close: Apr 6, 2026, 4:00 PM EDT
27.80
+0.09 (0.32%)
After-hours: Apr 6, 2026, 7:41 PM EDT

HRMY Revenue

In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth. Harmony Biosciences Holdings had revenue of $243.78M in the quarter ending December 31, 2025, with 21.12% growth.

Revenue (ttm)
$868.45M
Revenue Growth
+21.51%
P/S Ratio
1.85
Revenue / Employee
$2,964,003
Employees
293
Market Cap
1.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Immunocore Holdings400.02M
AnaptysBio234.60M
Nurix Therapeutics83.98M
Recursion Pharmaceuticals74.68M
Intellia Therapeutics67.67M
Nanobiotix38.27M
Oculis Holding AG1.51M
Revenue Rankings

HRMY News

More News